Mark Fraley
Senior Principal Scientist at Merck
Based in West Point, United States
7-day free trial · no credit card
Seniority
Director
Department
Science
Location
West Point
Industry
Pharmaceutical Manufacturing
Company size
45K
Contact information
Reveal Mark's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
m•••••••@merck.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Mark Fraley
I have worked as a medicinal chemist at Merck for 27 years. I have broad experience in oncology, infectious disease, and neuroscience, and extensive knowledge of preclinical and early clinical drug development. I have a proven track record for delivering quality clinical candidates to Merck's development pipeline. My accomplishments at Merck include leading the Team that designed and developed Ubrelvy (ubrogepant) and Qulipta (atogepant) for the treatment and prevention of migraine, respectively. Ubrelvy is the first small molecule CGRP receptor antagonist (and first orally active Family B GPCR antagonist) to be approved as a drug.
Decision-makers
Other people at Merck
- SSDirector
Stefano Subrizi
Associate Director, Europe and Canada Planning Lead · Operations
- DAOther
Diana Altshuler
Director of Ascvd, Global Scientific & Value Content, General Medicine · Other
- DYOther
Diane Yen
Project Leader, Project and Pipeline Management · Other
- CKDirector
Cheol K. Chung
Director · Operations
- BGStaff
Brittany Gay
Postdoctoral Research Fellow · Research & Development
Build a list of verified contacts at Merck
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Mark
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime